Chemours Company, a spin-off from DuPont, with market positions in titanium technologies, fluoroproducts, and chemical solutions, launched as an independent, publicly traded corporation on July 1, 2015. The company’s common stock began trading under the New York Stock Exchange symbol “CC.”

Chemours, formerly part of DuPont’s performance chemicals business, had 2014 sales of $6.4 billion. Titanium technologies represent the largest segment with 2014 sales of $2.9 billion followed by fluoroproducts at $2.3 billion, and chemical solutions (cyanide-based and sulfur-based products)at $1.2 billion. The company’s sales are primarily to industrial markets. The company’s fluoroproducts are principally for industrial markets, but also include products sold to the pharmaceutical industry, such as fluorine-based intermediates or fluorine-based plastics used in components for chemical, pharmaceutical, and biopharmaceutical production.

Source: Chemours